Navigation Links
Synchrotron gives insight into green energy enzymes
Date:12/4/2012

UC Davis chemists have been using a Japanese synchrotron to get a detailed look at enzymes that could help power the green economy. The work was published online Nov. 8 by the journal Angewandte Chemie and is featured on the cover of the Nov. 26 issue.

One option for powering clean, environment friendly vehicles is to run them on hydrogen fuel rather than carbon-based fuels. Cheap catalysts to prepare hydrogen gas (H2) are key to this future "hydrogen economy."

Current man-made catalysts are based on the rare and precious metal platinum. But living cells contain enzymes called hydrogenases, based on the abundant metals nickel and iron, which can do the same job. Chemists are very interested in figuring out how these natural catalysts work and trying to mimic them.

Saeed Kamali, a postdoctoral researcher at UC Davis and Stephen Cramer, professor of chemistry have just published a study revealing new details of the iron-nickel complex at the heart of the natural hydrogenase. In collaboration with researchers at the Max Planck Institute in Germany and in the U.S., they used a technique called Nuclear Resonance Vibrational Spectroscopy (NRVS) and the SPring-8 synchrotron at the Japan Synchrotron Radiation Research Institute to probe the crystals and discovered new information about how the atoms in the complex can move.


'/>"/>
Contact: Andy Fell
ahfell@ucdavis.edu
530-752-4533
University of California - Davis
Source:Eurekalert

Page: 1

Related medicine news :

1. Stanford/Yale study gives insight into subtle genomic differences among our own cells
2. Queens research gives fresh hope to couples with unexplained infertility
3. New finding gives clues for overcoming tamoxifen-resistant breast cancer
4. $2.8M grant gives diverse students a healing opportunity
5. Tick in Mans Ear Gives Him Tinnitus
6. Renal denervation gives better outcomes than drugs in advanced heart failure
7. Human Airways Brush Mechanism Gives Clues to Lung Diseases
8. FDA Gives Nod to First Drug for Diabetic Eye Disease
9. FDA Gives Nod to New Breast Cancer Drug
10. Study Gives First Evidence That Adult Human Lungs Can Regrow
11. OC Firm Gives Back to Young Athletes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... An August 3rd article on Reuters covers ... of a report in JAMA (the Journal of the American Medical Association). The study found ... to achieve BMIs under 30, when compared to patients with lower BMIs. At present, weight ...
(Date:8/16/2017)... GA (PRWEB) , ... August 16, 2017 , ... ... new Inc. 5000. The company ranked #4429 on the newly released, 36th annual ... list represents a unique look at the most successful companies within the American economy’s ...
(Date:8/16/2017)... Brentwood, TN (PRWEB) , ... August 16, 2017 ... ... market-leading dermatology practice partnerships through affiliations and de novo development, today announced ... practice. , Cumberland Skin Surgery and Dermatology, with offices in both Hermitage ...
(Date:8/16/2017)... ... 16, 2017 , ... Paul Vitenas, MD, FACS , is honored to ... annual list identifies the nation’s top physicians, in a variety of specialties. This marks ... top of Castle Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards of Infection Control ... cycle, both between patient procedures and before storage, is a requisite practice crucial ... to the prevention of disease transmission and nosocomial infection as cleaning and HLD.” ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... president, effective Aug. 7, 2017. ... other interests and will serve as president emeritus during a ... us in multiple leadership roles since he joined Diplomat with ... has provided decisive, strategic leadership which continues to benefit our ...
(Date:8/3/2017)... Aug. 3, 2017  Opioid addiction and other drugs ... healthcare costs and threatening outcomes, were problems taken on ... IVD industry that support them, met this week. This ... said that drugs of abuse, procalcitonin and acute kidney ... the organization,s 69th meeting in San Diego, ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: